Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
Sumitomo Dainippon Pharma Co (DNPUF) Stock Price & Analysis
6 Followers
DNPUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.03 - $5.22
Previous Close$2.16
Volume1.57K
Average Volume (3M)7.44K
Market Cap
$857.50M
Enterprise Value$1.01B
Total Cash (Recent Filing)¥288.26B
Total Debt (Recent Filing)¥249.71B
Price to Earnings (P/E)-0.4
Beta0.32
Next Earnings
Jul 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.41
Shares Outstanding397,900,154
10 Day Avg. Volume5,047
30 Day Avg. Volume7,443
Standard Deviation0.10
R-Squared0.06
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
DNPUF FAQ
What was Sumitomo Dainippon Pharma Co Ltd’s price range in the past 12 months?
Sumitomo Dainippon Pharma Co Ltd lowest stock price was $2.03 and its highest was $5.22 in the past 12 months.
What is Sumitomo Dainippon Pharma Co Ltd’s market cap?
Currently, no data Available
When is Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date?
Sumitomo Dainippon Pharma Co Ltd’s upcoming earnings report date is Jul 29, 2024 which is in 71 days.
How were Sumitomo Dainippon Pharma Co Ltd’s earnings last quarter?
Sumitomo Dainippon Pharma Co Ltd released its earnings results on May 14, 2024. The company reported -$3.344 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.344.
Is Sumitomo Dainippon Pharma Co Ltd overvalued?
According to Wall Street analysts Sumitomo Dainippon Pharma Co Ltd’s price is currently Overvalued.
Does Sumitomo Dainippon Pharma Co Ltd pay dividends?
Sumitomo Dainippon Pharma Co Ltd does not currently pay dividends.
What is Sumitomo Dainippon Pharma Co Ltd’s EPS estimate?
Sumitomo Dainippon Pharma Co Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sumitomo Dainippon Pharma Co Ltd have?
Sumitomo Dainippon Pharma Co Ltd has 397,900,150 shares outstanding.
What happened to Sumitomo Dainippon Pharma Co Ltd’s price movement after its last earnings report?
Sumitomo Dainippon Pharma Co Ltd reported an EPS of -$3.344 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.504%.
Which hedge fund is a major shareholder of Sumitomo Dainippon Pharma Co Ltd?
Currently, no hedge funds are holding shares in DNPUF
---
Sumitomo Dainippon Pharma Co Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-59.39%
12-Months-Change
Fundamentals
Return on Equity
-105.14%
Trailing 12-Months
Asset Growth
-29.67%
Trailing 12-Months
Company Description
Sumitomo Dainippon Pharma Co Ltd
Sumitomo Dainippon Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
---
Technical Analysis
---